Literature DB >> 19367058

Polycystic ovary syndrome and prolactinoma association.

Irfan Yavasoglu1, Mert Kucuk, Adil Coskun, Engin Guney, Gurhan Kadikoylu, Zahit Bolaman.   

Abstract

Hyperprolactinemia is the most common pituitary hormone hypersecretion syndrome in both men and women. Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting 5%-10% of reproductive age women. Here, we present a patient with irregular menses, obesity, hirsutism and infertility, and hyperprolactinemia who was diagnosed as PCOS and prolactinoma and admitted to our clinic. Prolactinoma and PCOS association is a rare condition. This 33-year-old woman was admitted to the internal medicine outpatient clinic for irregular menses, obesity, hirsutism and infertility, and hyperprolactinemia. Her laboratory results were as follows: prolactin was 74 ng/mL (normal range:1.8-20.3 ng/mL). Pelvic ultrasonography was correlated with polycystic ovary syndrome. Pituitary MRI showed 6x8 mm microadenoma at left half. Bromocriptine was started with 1.25 mg/day and increased to 5 mg/day. After six months of bromocriptine treatment her prolactin level was normal and no adenoma was detected in pituitary MRI. PCOS and prolactinoma association should be taken into account in PCOS cases with mild hyperprolactinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367058     DOI: 10.2169/internalmedicine.48.1829

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.

Authors:  Laura D Ratner; Betina Gonzalez; Petteri Ahtiainen; Noelia P Di Giorgio; Matti Poutanen; Ricardo S Calandra; Ilpo T Huhtaniemi; Susana B Rulli
Journal:  Endocrinology       Date:  2012-11-01       Impact factor: 4.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.